Clinical Research Directory
Browse clinical research sites, groups, and studies.
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
Sponsor: University of Alabama at Birmingham
Summary
The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend against certain types of bacteria. We will give two different types of vaccine and evaluate the effectiveness of antibodies produced by each vaccine in killing bacteria.
Official title: Novel Serotype Alert: Investigate New Pneumococcal Conjugate Vaccines for Inducing Cross-protection Against Newly Discovered Serotype 33E and Putative Novel Serogroup 33 Serotypes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2026-03
Completion Date
2027-08
Last Updated
2026-03-13
Healthy Volunteers
Yes
Conditions
Interventions
Pneumococcal Vaccine
PCV
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States